Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
Treatment of multiple sclerosis with anti-CD20 antibodies.
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
Natural History of Multiple Sclerosis Symptoms
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Generic Midamor
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials

Pages